Skip to main content
. Author manuscript; available in PMC: 2024 May 30.
Published in final edited form as: J Mol Cell Cardiol. 2021 Oct 29;163:156–166. doi: 10.1016/j.yjmcc.2021.10.008

Fig. 5.

Fig. 5.

(A) Change in the postinfarction compensatory response with the administration of nitroglycerin, including: measured heart rate (HR), computed systemic vascular resistance (SVR), fitted end-systolic elastance of the non-infarcted region En, and fitted stressed blood volume (SBV). The change in computed mean arterial pressure (MAP) from postinfarction is also shown. (B) Change in the postinfarction compensatory response with the administration of dobutamine. For both nitroglycerin and dobutamine, no change is indicated by the gray dashed line and a significant mean change for all animals is indicated by a dark solid line (p < 0.05). Paired parametric t-tests were performed on all metrics except MAP, which failed the normality test and was analyzed with a Wilcoxon matched-pairs signed rank test.